a brief account of the concept of hormone dependence in breast neoplasia is followed by the presentation of results obtained with an association of medroxyprogesterone acetate ( map ) and 2-bromo-alpha-ergocriptine ( cb 154 ) in 14 women with metastatic cancer of the breast , hormone dependent due to the presence of the cytoplasmic receptor for 17-beta-oestradiol .
C1458155
of the
C0065864
medroxyprogesterone acetate